tiprankstipranks
Trending News
More News >

New Portfolio Jan 2023 - New Portfolio

Assen

New Portfolio Jan 2023
Individual Investor
Ranked #532,543 out of 852,106 TipRanks' Investors
Success Rate
42%
47 out of 113
profitable transactions
Average Return
2.64%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 0.50%
6-Month Return▲ 11.36%
12-Month Return▲ 1.76%
YTD Return▲ 0.67%
Total Return▲ 10.30%

Best Trade

Opened at
Closed at-
Gain▲ 298.30%

Bio

LT focused portfolio with primary investment in EU based companies

Performance

12.88%0-12.88%
▲ 7.60%
▲ 2.30%
▲ 2.89%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 3.98%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 0.74%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 3.59%
Oct 2025
▼ 3.58%
▲ 0.19%
▲ 0.39%
Nov 2025
▼ 0.10%
▲ 0.08%
▼ 0.20%
Dec 2025
▲ 4.06%
▲ 1.47%
▲ 0.75%
Jan 2026
▲ 0.50%
▼ 0.08%
Feb 2026
TipRanks AverageS&P 500Investor Portfolio
▲ 7.60%▲ 2.30%▲ 2.89%
▲ 2.76%▲ 2.05%▲ 3.98%
▲ 12.88%▲ 3.56%▲ 0.74%
▲ 10.96%▲ 2.38%▲ 3.59%
▼ 3.58%▲ 0.19%▲ 0.39%
▼ 0.10%▲ 0.08%▼ 0.20%
▲ 4.06%▲ 1.47%▲ 0.75%
▲ 0.50%▼ 0.08%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Sanofi
0%
▼ 6.86%
4
Sell
Aug 17, 2025
Kering SA
0%
▼ 28.85%
6
Sell
Aug 17, 2025
Novo Nordisk
21.85%
▼ 29.12%
8
Buy
Aug 17, 2025
The Estée Lauder Companies
0%
▲ 8.11%
7
Sell
Aug 17, 2025
Tesla
9.35%
▲ 71.11%
3
Buy
Aug 17, 2025
Nvidia
8.22%
▲ 121.64%
5
Buy
Aug 17, 2025
EssilorLuxottica SA
5.39%
▲ 14.71%
3
Buy
Aug 17, 2025
LVMH Moet Hennessy Louis Vuitton
11.78%
▼ 7.25%
4
Buy
Aug 17, 2025
Barry Callebaut AG
0%
▼ 10.45%
2
Sell
Aug 17, 2025
Eli Lilly & Co
7.81%
▲ 48.30%
1
Open
Aug 17, 2025
Remy Cointreau
1.03%
▼ 58.66%
7
Buy
May 14, 2025
Brown Forman A
0.61%
▼ 38.23%
4
Buy
May 14, 2025
L'Oreal
3.4%
▼ 3.63%
2
Buy
May 14, 2025
TotalEnergies SE
5.31%
▲ 9.95%
2
Buy
May 14, 2025
Air Liquide
▲ 13.40%
4
Close
Sep 27, 2024
Ferrari
0%
▼ 26.01%
2
Sell
Sep 27, 2024
AXA SA
0%
▲ 21.74%
2
Sell
Sep 27, 2024
Alibaba
0%
▲ 97.52%
2
Sell
Sep 27, 2024
Compagnie Financiere Richemont SA
▼ 5.60%
2
Close
Sep 27, 2024
Bristol-Myers Squibb
0%
▲ 39.66%
2
Sell
Sep 27, 2024